- One of the first success stories of The Ganesha Lab was promoting a portable corneal topographer that allows analysis of the curvature of the cornea.
- Through synergy, it seeks not only to obtain sufficient funds but also to promote projects to the international market.
- The new objective of the project is to invest funds in Mexican and Latin American companies.
There are companies focused on offering solutions for access to health, food shortages, population aging and emerging threats. Many times they have promising ideas but the biggest problem is always the lack of capital. To offer a solution there The Ganesha Lab and now for the first time it arrives in Mexico.
The goal of this biotech accelerator is to make synergy with enterprises and perfect or improve their business models, products, patents and equipment. In this way they can be projected to international markets, particularly the United States.
Successful projects
The incubator, led by Markus Schreyer, founding CEO-former director of Thermo Fisher Scientific in Latam- will soon be a Venture Capital, so it plans to invest funds in Mexican and Latin American companies.
“We are looking for early-stage biotech startups with the potential and vision to make a global impact.”
At this point, it should be noted that there is already a first Mexican success story in the medical area. Is about Bleps Visionwhich developed a portable corneal topographer which allows analysis of the cornea curvatureidentifying, for example, possible deformations.
In this regard, Catalina Fernández, Program Manager of The Ganesha Labpoints out that the internationalization of companies or ventures focused on biotechnology is vital to change the quality of life of people and to generate impact.
And what is the proposal for Mexico and LATAM?
Through a very broad program, startups are allowed to join a work system that will give them access to mentoring and workshops for three months, focused on topics such as Business Base Line, Clients & Markets, Global Success, Scaling & Capital Raise – to individual meetings with partners and experts in the field.
Subsequently, the entrepreneurs participate in a two-week virtual soft-landing program in the United States, carried out with the Cambridge Innovation Center Miami (CIC).
Once the program is over, a final event is held where the participants present their solutions -by means of a pitch- before a select international jury, on which occasion the two best-prepared companies to access the international market are selected and which have great scaling potential.
The winners gain access to a program of International Market Validation (International Market Validation or IMV, for its acronym in English) where they can scale with real and face-to-face work with investors, mentors and potential clients, for two months in the United States.
For Mike Lemcke, associate director of the UC Davis Venture Catalyst, a key challenge is accessing the global industry.
“We help startups transform their mentality, solidify their business model and take the next step to achieve a presence in international markets through global soft landings. We are delighted to partner with TGL, through our Worldwide Accelerated Research Partnerships (WARP) program.”